Csl Behring
Clinical trials sponsored by Csl Behring, explained in plain language.
-
Race against time: can a clotting drug save more trauma victims?
Disease control TerminatedThis large study tested whether a single dose of a blood-clotting drug (BE1116) could help people survive severe bleeding after a traumatic injury. Over 1,300 patients were randomly given either the drug or a placebo to see if it reduced deaths within the first 6 and 24 hours. Th…
Phase: PHASE3 • Sponsor: CSL Behring • Aim: Disease control
Last updated Apr 02, 2026 01:41 UTC
-
New injection trial aims to tame debilitating muscle and skin disease
Disease control TerminatedThis study tested whether regular injections of an immune-boosting medication (IgPro20) could help control the symptoms of dermatomyositis, a rare disease that causes muscle weakness and skin rashes. It involved 134 adults who received either the active injections or a placebo fo…
Phase: PHASE3 • Sponsor: CSL Behring • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC